US researchers have examined the outcomes of patients who relapsed after chimeric antigen receptor (CAR) T cell therapy for multiple myeloma.
The team believe this analysis will aid future research and help define optimal treatment strategies.
CAR...
1 year ago
The number of autologous chimeric antigen receptor (CAR) T-cell therapy undergoing testing for chronic lymphocytic leukaemia (CLL) demonstrates the promise for this treatment, according to a new analysis.
Compiled by the London-based data analytic...
1 year ago
